Improved Growth Outlook and Better-Than-Expected Results Boosted Tandem Diabetes Care (TNDM) in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same...
TNDM
How Device Correction and Securities Probe Will Impact Tandem Diabetes Care (TNDM) Investors
Rosen Law Firm is investigating potential securities claims on behalf of Tandem Diabetes Care shareholders after the company previously issued...
A Look At Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Recovery
Recent share performance and business snapshot Tandem Diabetes Care (TNDM) has been under pressure recently, with the stock showing a...
How Recent Product Correction and Legal Inquiry May Impact Tandem Diabetes Care’s (TNDM) Investment Outlook
Earlier this month, Tandem Diabetes Care issued a voluntary medical device correction addressing a potential risk that certain t:slim X2...
